Russia Quietly Changed Its Space Station Plans. Here's What That Means The proposed Russian Orbital Station will stick to a ...
TipRanks on MSN
Ultragenyx completes BLA filing for GSDIa gene therapy
Ultragenyx Pharmaceutical ( ($RARE) ) just unveiled an update. On December 30, 2025, Ultragenyx Pharmaceutical announced it had completed the ...
Murphy’s law worked hard in 2025.A year full of “what else can go wrong”, and then the wrong proceeds to make its way in, ...
If approved, DTX401 will be the first therapy approved to treat the underlying cause of GSDIaNOVATO, Calif., Dec. 30, 2025 ...
NASA astronaut Zena Cardman processes bone cell samples inside the Kibo laboratory module's Life Science Glovebox. NASA 2025 ...
Artemis II will send astronauts around the moon in February-April 2026, marking NASA’s first crewed lunar mission in 53 years ...
Utilize AI to analyze application runtime data (e.g., rendering time, communication latency), obtain optimization suggestions (such as reducing component re-rendering, reusing hardware connections), ...
Amentum (NYSE: AMTM) delivered advanced end-to-end ground systems engineering for a key Artemis II launch rehearsal at the ...
It's been a tough year for automakers, from the loss of federal tax credits causing a greater slump in EV sales to the ...
BMW M4 Competition (G82) xDrive gets ModifiedAs mentioned in my primary ownership report and also in several posts that the ...
A look at NASA’s Apollo 8 mission, its impact in 1968, and how Artemis 2 could shape the future of human spaceflight in 2026 ...
Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) today announced that it has completed the rolling submission of its Biologics License Application (BLA) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback